JamesDavidBrandtMD

Ophthalmology • Sacramento, CA

Anterior Segment Related, Cataract Related, Glaucoma Related, Pediatric & Strabismus

Professor & Director, Glaucoma Service

Join to view full profile

Dr. Brandt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Brandt's full profile

Already have an account?

Office
4860 Y St Ste 2400
UC Davis Eye Center
Sacramento, CA 95817
Phone+1 916-734-6818

Fax+1 916-734-0411
Is this information wrong?

Summary

James D. Brandt, MD, is Professor of Ophthalmology & Vision Science, Director of the Glaucoma Service and Vice-Chair for International Programs & New Technologies at the University of California, Davis in Sacramento, California.

After receiving a BS degree from Yale University and an MD degree from Harvard Medical School, he pursued a two-year post-doctoral research fellowship in glaucoma-related pharmacology and cell biology at the Schepens Eye Research Institute in Boston before his residency at the USC/LA County/Doheny Eye Institute. He completed a glaucoma fellowship at the Wills Eye Hospital before joining the UC Davis faculty in 1989.

Dr. Brandt’s clinical practice is limited to glaucoma, with a particular focus on infantile and pediatric glaucoma. Dr. Brandt is a frequent volunteer faculty member with ORBIS International, traveling worldwide to train glaucoma specialists in the management of pediatric glaucoma.

Dr. Brandt has served as the Principal Investigator of numerous clinical trials, including the Ocular Hypertension Treatment Study (OHTS). As an OHTS principal investigator, Dr. Brandt initiated the effort to measure central corneal thickness (CCT) as a potential risk factor for glaucoma and has continued to investigate the role of CCT in glaucoma diagnosis and pathogenesis.

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Glaucoma, 1988 - 1989
University of Southern California/LAC+USC Medical CenterResidency, Ophthalmology, 1985 - 1988
Eye Research InstitutePost-Doctoral Fellowship, Cell Biology & Pharmacology, 1983 - 1985
University of MinnesotaInternship, Surgery, 1982 - 1983
Harvard Medical SchoolClass of 1982, M.D.
Yale UniversityBS, Biology, 1973 - 1978

Certifications & Licensure

CA State Medical License 1984 - 2026
MA State Medical License 1983 - 2011
PA State Medical License 1988 - 2000
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Senior Achievement Award American Academy of Ophthalmology, 2004
Secretariat Award American Academy of Ophthalmology, 2004
Best Doctors in America 1996, 1998
Honor Award American Academy of Ophthalmology, 1996
Heed Ophthalmology Fellowship 1989
Fellow (FAAO) American Academy of Ophthalmology
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Primary Tube Versus Trabeculectomy Study Start of enrollment: 2008 Apr 01
Completed
Phase 4
Baerveldt Plate Area Comparison (BPAC) Start of enrollment: 2010 Jun 01
Terminated
Not Applicable
Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension Start of enrollment: 2013 Oct 23
Completed
Phase 2

Publications & Presentations

PubMed

Glaucoma Following Cataract Surgery in Children-Finally, a Clue.
James D Brandt, Suma P Shankar> ;JAMA Ophthalmology. 2023 Sep 1
Preparing the Ocular Surface for a Boston Keratoprosthesis Type 1 Through En Bloc Minor Salivary Gland Transplantation and Mucous Membrane Grafting in End-Stage Steven...
Alejandro Arboleda, Ragini Phansalkar, Guillermo Amescua, Wen-Shin Lee, James D Brandt, Mark J Mannis, Andrea L Kossler, Charles C Lin> ;Cornea. 2023 Jul 1
Reply.
Steven J Gedde, Kin Sheng Lim, Keith Barton, Saurabh Goyal, Iqbal I Ahmed, James D Brandt> ;Ophthalmology. 2023 Jul 1
3 citations
Geographic Information System Mapping of Social Risk Factors and Patient Outcomes of Pediatric Glaucoma.
Kevin W Chen, Angela Jiang, Chandni Kapoor, Jeffrey R Fine, James D Brandt, Jenny Chen> ;Ophthalmology. Glaucoma. 2022 Nov 23
28 citations
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 5 Years of Follow-up.
Steven J Gedde, William J Feuer, Kin Sheng Lim, Keith Barton, Saurabh Goyal, Iqbal I Ahmed, James D Brandt> ;Ophthalmology. 2022 Dec 1
19 citations
Postoperative Complications in the Primary Tube Versus Trabeculectomy Study During 5 Years of Follow-up.
Steven J Gedde, William J Feuer, Kin Sheng Lim, Keith Barton, Saurabh Goyal, Iqbal I Ahmed, James D Brandt> ;Ophthalmology. 2022 Dec 1
3 citations
Use of a Novel Microshunt in Refractory Childhood Glaucoma: Initial Experience in a Compassionate Use/Early Access Cohort.
James D Brandt> ;American Journal of Ophthalmology. 2022 Jul 1
Letter to the editor regarding: Congenital aniridia - A comprehensive review of clinical features and therapeutic approaches.
James D. Brandt> ;Survey of Ophthalmology. 2021 Nov 6
12 citations
Consensus Statement for the Management and Treatment of Sturge-Weber Syndrome: Neurology, Neuroimaging, and Ophthalmology Recommendations.
, , , , , , , , , , , , , , , > ;Pediatric Neurology. 2021 Aug 1
21 citations
Assessment of Cumulative Incidence and Severity of Primary Open-Angle Glaucoma Among Participants in the Ocular Hypertension Treatment Study After 20 Years of Follow-up.
Michael A. Kass, Dale K Heuer, Eve J. Higginbotham, Richard K. Parrish, Cheryl L. Khanna, James D. Brandt, Joern B. Soltau, Chris A. Johnson, John L. Keltner, Julia Hu...> ;JAMA Ophthalmology. 2021 Apr 15
6 citations
Multicenter Analysis of Electronic Health Record Use among Ophthalmologists.
Sally L. Baxter, Helena E. Gali, Mitul C Mehta, Scott E. Rudkin, John G. Bartlett, James D. Brandt, Catherine Q. Sun, Marlene Millen, Christopher A. Longhurst> ;Ophthalmology. 2021 Jan 1
Reply.
Steven J Gedde, William J Feuer, Kin Sheng Lim, Keith Barton, Saurabh Goyal, Iqbal I Ahmed, James D Brandt> ;Ophthalmology. 2020 Sep 1
Reply.
Steven J Gedde, William J Feuer, Kin Sheng Lim, Keith Barton, Saurabh Goyal, Iqbal I Ahmed, James D Brandt> ;Ophthalmology. 2020 Sep 1
Reply.
Steven J Gedde, William J Feuer, Kin Sheng Lim, Keith Barton, Saurabh Goyal, Iqbal I K Ahmed, James D Brandt> ;Ophthalmology. 2020 Jul 1
6 citations
Combined Dexamethasone Intravitreal Implant and Glaucoma Drainage Device Placement for Uveitic Glaucoma.
Tran Nguyen, Han Kim, Christy Mielke, Anna C. Momont, James D. Brandt, Yao Liu> ;Journal of Glaucoma. 2020 Apr 1
35 citations
Central Corneal Thickness in the Ocular Hypertension Treatment Study (OHTS).
James D Brandt, Julia A Beiser, Michael A Kass, Mae O Gordon> ;Ophthalmology. 2020 Apr 1
10 citations
A Comparison of Trabeculectomy Surgery Outcomes With Mitomycin-C Applied by Intra-Tenon Injection Versus Sponge.
Michele C. Lim, Betty Hom, Mitchell Watnik, James D. Brandt, Allison R. Altman, Tania Paul, Melissa G. Tong> ;American Journal of Ophthalmology. 2020 Mar 12
14 citations
International Study of Childhood Glaucoma.
Maria Papadopoulos, Elizabeth A. Vanner, Alana L. Grajewski, Arijit Mithra, Manju R Pillai, Swati Upadhyaya, Ganesh Venkataraman, Ta Chen Peter Chang, Alana Grajewski,...> ;Ophthalmology. Glaucoma. 2020 Mar 1
76 citations
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.
Steven J Gedde, William J Feuer, Kin Sheng Lim, Keith Barton, Saurabh Goyal, Iqbal I K Ahmed, James D Brandt> ;Ophthalmology. 2020 Mar 1
12 citations
Trabeculotomy Ab Interno With the Trab360 Device for Childhood Glaucomas
Raymond G. Areaux, Alana L. Grajewski, Saranya Balasubramaniam, James D. Brandt, Amber Jun, Beth Edmunds, Michael Shyne, Elena Bitrian> ;American Journal of Ophthalmology. 2020 Jan 1
78 citations
Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies.
Robert N. Weinreb, Jeffrey M. Liebmann, George A. Cioffi, Ivan Goldberg, James D. Brandt, Chris A. Johnson, Linda M. Zangwill, Susan Schneider, Hanh Badger, Marina Bej...> ;Ophthalmology. 2018 Dec 1
87 citations
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Steven J Gedde, William J Feuer, Wei Shi, Kin Sheng Lim, Keith Barton, Saurabh Goyal, Iqbal I K Ahmed, James Brandt> ;Ophthalmology. 2018 May 1
2 citations
Stop "Adjusting" Intraocular Pressure Measurements.
James D. Brandt> ;JAMA Ophthalmology. 2017 Jun 1
40 citations
Long-term Safety and Efficacy of a Sustained-Release Bimatoprost Ocular Ring.
James D. Brandt, Harvey Dubiner, Robert Benza, Kenneth N Sall, Gary Walker, Charles P. Semba> ;Ophthalmology. 2017 Oct 1
12 citations
Tube Fenestration in the Tube Versus Trabeculectomy Study
Kateki Vinod, James D. Brandt, Steven J. Gedde, William J. Feuer, Wei Shi> ;Ophthalmology. 2016 Oct 1
Join now to see all

Journal Articles

Adrenergic Stimulation of Ciliary Epithelium Induces Plasma Membrane Internalization.
Brandt JD, Bartels SP & Neufeld AH, Investigative Ophthalmology & Visual Science 28(3):431-444
Should we treat Ocular Hypertension?
Brandt JD, Review of Ophthalmology 1(8):54-55
Baseline demographics and clinical characteristics of patients enrolled in the Ocular Hypertension Treatment Study.
Gordon MO, Kass MA, Heuer DK, Higginbotham EJ, Parrish RK for the Ocular Hypertension Treatment Study Group, Archives of Ophthalmology 117(5):573-583
Na-K-Cl cotransport regulates intracellular volume and monolayer permeability of trabecular meshwork cells.
O’Donnell ME, Brandt JD & FE Curry FE, American Journal of Physiology (Cell Physiology) 37:C1067-C1074
Confirmation of Visual Field Abnormalities in the Ocular Hypertension Treatment Study.
Keltner JL, Johnson CA, Quigg JM, Cello KE, Gordon MO and Kass MA for the Ocular Hypertension Treatment Study Group, Archives of Ophthalmology 118(9):1187-1194
Effects of dexamethasone on Na-K-Cl cotransport activity and protein expression in trabecular meshwork cells.
Putney LK, Brandt JD & O’Donnell ME, Investigative Ophthalmology & Visual Science 38(6):1229-1240
Contralateral effect of topical ß-adrenergic antagonists in one-eyed trials in the Ocular Hypertension Treatment Study.
Piltz J, Gross R, Shin DH, Beiser JA, Dorr DA, Kass MA, Gordon MO for the Ocular Hypertension Treatment Study Group, American Journal of Ophthalmology 130(4):441-453
Cases in Controversy: Early Detection of Glaucoma.
Cioffi GA, Brandt JD & Gagliuso D, Journal of Glaucoma 7(3):182-186
The Ocular Hypertension Treatment Study: Reproducibility of Cup/Disk Ratio over time at an Optic Disc Reading Center.
Feuer WJ, Parrish RK, II, Schiffman JC, Anderson DR, Budenz DL, Wells M-C,. Hess DJ, Kass MA, Gordon MO for the Ocular Hypertension Treatment Study Group, American Journal of Ophthalmology 133(1):19-28
Baseline visual field characteristics in the Ocular Hypertension Treatment Study.
Johnson CA, Keltner JL, Cello KE, Edwards M, Kass MA, Gordon MO, Budenz DL, Gaasterland DE, Werner E for the Ocular Hypertension Treatment Study Group, Ophthalmology 109:432-437
The Ocular Hypertension Treatment Study: A Randomized Trial Determines that Topical Ocular Hypotensive Medication Delays or Prevents the Onset of Primary Open Angle ...
Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JK, Parrish RK, Wilson MR, Gordon MO and the Ocular Hypertension Treatment Study Group, Archives of Ophthalmology 120(6):701-713
Classification of visual field abnormalities in the Ocular Hypertension Treatment Study.
Johnson CA, Keltner JL, Cello KE, Edwards M, Bandermann SE, Kass MA, Gordon MO for the Ocular Hypertension Treatment Study Group, Archives of Ophthalmology 121:643-650
Effects of Na-K-2Cl Cotransport regulators on outflow facility in calf and human eyes in vitro.
Al-Aswad LA, Gong H, Lee D, O’Donnell ME, Brandt JD, Ryan WJ, Schroeder A & Erickson KA, Investigative Ophthalmology & Visual Science 40(8):1695-1701
The Ocular Hypertension Treatment Study: Topical Ocular Hypotensive Medication Delays or Prevents Primary Open Angle Glaucoma in African American Individuals.
Higginbotham EJ, Gordon MO, Beiser JA, Drake MV, Bennett GR, Wilson MR, Kass MA for the Ocular Hypertension Treatment Study Group, Archives of Ophthalmology 122:813-820
Baseline risk factors for the development of POAG in the Ocular Hypertension Treatment Study.
Coleman AL, Gordon MO, Beiser JA, Kass MA for the Ocular Hypertension Treatment Study Group, American Journal of Ophthalmology 138(4):684-685
Incorporating the results of the Ocular Hypertension Treatment Study into clinical practice. Letter to Editor.
Kass MA, Gordon MO, Kymes SM for the Ocular Hypertension Treatment Study Group, Archives of Ophthalmology 123:1021-1022
Normal visual field test results following glaucomatous visual field endpoints in the Ocular Hypertension Treatment Study.
Keltner JL, Johnson CA, Levine RA, Fan JJ, Cello KE, Kass MA, Gordon MO for the Ocular Hypertension Treatment Study Group, Archives of Ophthalmology 123:1201-1206
Six-month Comparison of Bimatoprost Once-Daily and Twice-Daily with Timolol Twice-Daily in Patients with Elevated Intraocular Pressure.
Sherwood MJ & Brandt JD for the Hypotensive Lipid Study Groups 1 & 2, Survey of Ophthalmology 45(Suppl 4):S361-S368
Test-retest reproducibility of optic disk deterioration detected from stereophotographs by masked graders.
Parrish RK, Schiffman JC, Feuer WJ, Anderson DR, Budenz DL, Wells-Albornoz M-C, Vandenbrouke R, Kass MA, Gordon MO for the Ocular Hypertension Study Group, American Journal of Ophthalmology 140:762-764
Pharmacological targeting of the trabecular meshwork.
Brandt JD, Glaucoma – Perspectives in Practice
Asymmetries and visual field summaries as predictors of glaucoma in the Ocular Hypertension Treatment Study (OHTS).
Levine RA, Demirel S, Fan JJ, Keltner JL, Johnson CA, Kass MA for the Ocular Hypertension Study Group, Investigative Ophthalmology & Visual Science 47:3896-3903
The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study.
Keltner JL, Johnson CA, Anderson DR Levine RA, Fan JJ, Cello KE, Quigley HA, Budenz DL, Parrish RK, II, Kass MA, Gordon MO for the Ocular Hypertension Treatment Stud..., Ophthalmology 113(9):1603-1612
The Ocular Hypertension Treatment Study (OHTS): An Executive Summary for the Busy Clinician.
Brandt JD & Kass MA, Vision Pan-America 1(1):4-5
Topical Ocular Hypotensive Medication and Lens Opacification: Evidence From the Ocular Hypertension Treatment Study.
Herman DC, Gordon MO, Beiser JA, Chylack LT, Lamping KA, Schein OD, Soltau JB, Kass MA and the Ocular Hypertension Treatment Study Group, American Journal of Ophthalmology 142:800– 800
Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study.
Budenz DL, Anderson DR, Feuer WJ, Beiser JA, Schiffman J, Parrish RK, II, Piltz-Seymour JR, Gordon MO, Kass MA for the Ocular Hypertension Treatment Study Group, Ophthalmology 113(12):2137-2143
Join now to see all

Books/Book Chapters

Optics for Ophthalmologists – A Board-Review Manual
Sadun, AA & Brandt JDSpringer-Verlag, New York
Consensus Series 4.
Chapter: Intraocular Pressure
Weinreb RN, Brandt JDEditors: Garway-Heath D & Medeiros F.Kugler Publications, The Netherlands
Duane’s Clinical Ophthalmology.
Chapter: Surgery for Congenital Glaucoma
Brandt JDJ. B. Lippincott, PhiladelphiaEdition 6,
Ophthalmology.
Chapter: Trabeculotomy and Goniotomy
Brandt JDEditors: Yanoff & Duker.Mosby International, London
Ophthalmology.
Chapter: Congenital Glaucoma
Brandt JDEditors: Yanoff & Duker.Mosby International, London
Duane’s Clinical Ophthalmology.
Chapter: Surgery for Congenital Glaucoma
Brandt JDJ. B. Lippincott, Philadelphia
Ophthalmology.
Chapter: Trabeculotomy and Goniotomy
Page 1569 - 1576Brandt JDEditors: Yanoff & Duker.Mosby International, LondonEdition 2,
Ophthalmology.
Chapter: Congenital Glaucoma
Page 1475 - 1481Brandt JDEditors: Yanoff & Duker.Mosby International, LondonEdition 2,
Cornea.
Chapter: Glaucoma after Penetrating Keratoplasty
Brandt JD, Lim MC & O’Day DGEditors: Mannis & Kratchmer.Elsevier, LondonEdition 2,
Ophthalmology.
Chapter: What have we learned from the major glaucoma clinical trials
Brandt JD & Wilson MREditors: Grehn & Stamper.Springer, Germany
Answers in Glaucoma.
Chapter: What is the practical importance of pachymetry in the clinical evaluation of glaucoma
Brandt JDEditors: Susanna & Weinreb.Cultura Médica, Rio de Janeiro
Glaucoma.
Chapter: The Impact of Central Corneal Thickness and Corneal Biomechanics on Tonometry
Brandt JD, Roberts CR, Sherwood MB & Sheets CWEditors: Shaarawy, Sherwood, Hitchings & Crowston.Elsevier, London
Curbside Consultation in Glaucoma – 49 Clinical Questions.
Chapter: Should I measure central corneal thickness in all glaucoma patients? All Glaucoma Suspects
Brandt JDEditors: Heuer, Gedde & Lewis.Slack, Thorofare
Duane’s Clinical Ophthalmology.
Chapter: Surgery for Congenital Glaucoma
Brandt JD & Suhr, AWJ. B. Lippincott, Philadelphia
Ophthalmology.
Chapter: Congenital Glaucoma
Brandt JDEditors: Yanoff & Duker.Mosby International, LondonEdition 3,
Pearls of Glaucoma Consultation.
Chapter: Incorporating Central Corneal Thickness into Clinical Practice
Brandt JDEditors: Caprioli, Coleman, Law & Giaconi.Springer, Germany
Medical Treatment of Glaucoma.
Chapter: Medical Management of Glaucoma in Infants and Children
Page 267 - 271Brandt JDEditors: Weinreb RN, Araie M, Susanna R, Goldberg I, Migdal C & Liebmann J.Kugler Publications, Amsterdam
Join now to see all

Lectures

35th Annual Ophthalmology Symposium: Big Topics on the Big Island; An Update of Comprehensive Ophthalmology
UC Davis Health System, Waikoloa, Hawaii - 6/13/2012
35th Annual UC Davis Health System Eye Center Ophthalmology Symposium - Big Topics on the Big Island: An Update of Comprehensive Ophthalmology 2012
UC Davis Health System, Waikoloa, Hawaii - 6/13/2012
American Glaucoma Society 22nd Annual Meeting
American Glaucoma Society (AGS), New York, New York - 3/1/2012
New drugs in glaucoma.
San Diego Eye Bank Annual Course San Diego, California
Initial Treatment in Glaucoma – Medicines, Laser or Surgery?
San Diego Eye Bank Annual Course San Diego, California
Managing Cataract in the Glaucoma Patient.
San Diego Eye Bank Annual Course San Diego, California
Understanding Aqueous Humor Outflow at the Cellular Level.
Doheny Eye Institute / University of Southern California Los Angeles, California
Strategies for the Early Detection of Glaucoma.
Midwest Glaucoma Symposium Minneapolis, Minnesota
Glaucoma Clinical Trials – Translating their results into clinical practice.
Midwest Glaucoma Symposium Minneapolis, Minnesota
Understanding Aqueous Humor Outflow at the Cellular Level.
Brooke Army Medical Center University of Texas Medical Center San Antonio, Texas
Strategies for the Early Detection of Glaucoma.
Brooke Army Medical Center University of Texas Medical Center San Antonio, Texas
Managing Cataract in the Glaucoma Patient.
Brooke Army Medical Center University of Texas Medical Center San Antonio, Texas
Glaucoma Clinical Trials – Translating their results into clinical practice.
Brooke Army Medical Center University of Texas Medical Center San Antonio, Texas
Argon Laser Trabeculoplasty.
Ocular Drug & Surgery Update Laguna Niguel, California
Glaucoma in Infants & Children.
Wills Eye Hospital Philadelphia, Pennsylvania
Understanding Aqueous Humor Outflow at the Cellular Level.
Wills Eye Hospital Philadelphia, Pennsylvania
Strategies for the Early Detection of Glaucoma.
Wills Eye Hospital Philadelphia, Pennsylvania
Strategies for the Early Detection of Glaucoma.
Trinity College Dublin, Ireland
Glaucoma Drainage Devices in the Management of Recalcitrant Juvenile Glaucoma.
European Glaucoma Society London, England
Clinical Trials in Glaucoma: Translating Their Results Into Clinical Practice.
Kansas City Society of Ophthalmology & Otolaryngology Kansas City, MO
Refractive Surgery and the Glaucoma Patient.
Kansas City Society of Ophthalmology & Otolaryngology Kansas City, MO
The Prostamides.
Ocular Drug & Surgical Therapy Update Laguna Niguel, California
Phase III Comparison of AGN-192024 with Timolol – 3 and 6 month results.
Lumigan Consensus Meeting Prague, Czech Republic, 2000
Medical Therapy of Glaucoma.
3 rd International Glaucoma Symposium Prague, Czech Republic
Minimal Effective Treatment – Rethinking the Medical Management of Glaucoma.
Miami Ophthalmological Society Key Biscayne, FL
Join now to see all

Other

LEO Clinical Update on Glaucoma.
Mark B. Sherwood, James D. Brandt, Neil T
San Francisco
LEO Clinical Update on Glaucoma.
Mark B. Sherwood, James D. Brandt, Neil T
San Francisco
Measuring Outflow Resistance of an Eye.
Pan, Tingrui & Brandt, James D
A method for enhancing outflow of aqueous humor in treatment of glaucoma.
Brandt, James D., Martha E. O’Donnell & Fitz-Roy E. Curry
A method for enhancing outflow of aqueous humor in treatment of glaucoma.
Brandt, James D., Martha E. O’Donnell & Fitz-Roy E. Curry
A method for enhancing outflow of aqueous humor in treatment of glaucoma.
Brandt, James D., Martha E. O’Donnell & Fitz-Roy E. Curry
A method for enhancing outflow of aqueous humor in treatment of glaucoma.
Brandt, James D., Martha E. O’Donnell & Fitz-Roy E. Curry
Join now to see all

Press Mentions

$UC Davis Health Eye Center 1st to Try Microshunt for Refractory Childhood Glaucoma$
UC Davis Health Eye Center 1st to Try Microshunt for Refractory Childhood GlaucomaNovember 17th, 2022
Silicone Ring May Be Superior to Drops for Glaucoma PatientsMay 5th, 2016